Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyLearn more
Hematology · Nanfang Hospital · Guangzhou

Dr. Jiang Ling蒋玲

Associate Chief Physician

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

JL

Professional overview

Jiang Ling is an Associate Chief Physician in the Department of Hematology at Nanfang Hospital, specializing in diagnosis and treatment of common hematologic disorders, with research focus on risk-stratified diagnosis and drug resistance mechanisms in acute leukemia, and basic research on myelodysplastic syndromes.

SpecialtyHematology
Clinical titleAssociate Chief Physician
Academic roles—
DepartmentDepartment of Hematology
HospitalNanfang Hospital
CityGuangzhou

Areas of focus

Acute leukemiaFocuses on risk-stratified diagnosis and drug resistance mechanisms
Myelodysplastic syndromesConducts basic research

Background

  • 2013Earned a Ph.D. in Medicine from Southern Medical University
  • 2019Completed postdoctoral research at The University of Texas MD Anderson Cancer Center

Experience & recognition

  • Principal investigator of one National Natural Science Foundation of China (NSFC) project
  • Published 5 SCI-indexed papers and 6 core journal papers

Professional roles

  • Member, Leukemia and Myelodysplastic Syndromes Working Group, Hematology Branch, Guangdong Medical Doctor Association
  • Member, Red Blood Cell Diseases Working Group, Hematology Branch, Guangdong Medical Doctor Association

Frequently asked questions

What does Dr. Jiang Ling specialize in?

Specializes in diagnosis and treatment of common hematologic disorders, with research focus on risk-stratified diagnosis and drug resistance mechanisms in acute leukemia, and basic research on myelodysplastic syndromes.

Which hospital and department is Dr. Jiang Ling in?

Department of Hematology at Nanfang Hospital

Sources

Dr. Jiang Ling has not reviewed this page.